Krishna Institute of Medical Sciences Limited

KIMS

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026484

    Quarter₹ croreYoY
    Jun 2024327+9.5%
    Sept 2024363+14.9%
    Dec 2024348+15.0%
    Mar 2025346+13.5%
    Jun 2025373+14.1%
    Sept 2025430+18.4%
    Dec 2025442+27.2%
    Mar 2026456+31.9%
    Jun 2026484+29.5%
  • ₹ crore

    Jun 202631

    Quarter₹ crore
    Jun 20245
    Sept 20247
    Dec 202421
    Mar 202524
    Jun 202512
    Sept 202513
    Dec 202514
    Mar 202618
    Jun 202631
  • ₹ crore

    Jun 2026514

    Quarter₹ crore
    Jun 2024333
    Sept 2024370
    Dec 2024368
    Mar 2025370
    Jun 2025386
    Sept 2025443
    Dec 2025456
    Mar 2026474
    Jun 2026514
  • Cost structure
  • ₹ crore

    Jun 202685

    Quarter₹ crore
    Jun 202462
    Sept 202460
    Dec 202457
    Mar 202558
    Jun 202568
    Sept 202576
    Dec 202574
    Mar 202672
    Jun 202685
  • ₹ crore

    Jun 2026426

    Quarter₹ crore
    Jun 2024251
    Sept 2024271
    Dec 2024266
    Mar 2025260
    Jun 2025306
    Sept 2025356
    Dec 2025358
    Mar 2026378
    Jun 2026426
  • Exceptional items and tax
  • ₹ crore

    Jun 202689

    Quarter₹ crore
    Jun 202482
    Sept 202499
    Dec 2024102
    Mar 2025121
    Jun 202580
    Sept 202586
    Dec 202598
    Mar 202689
    Jun 202689
  • ₹ crore

    Jun 202622

    Quarter₹ crore
    Jun 202421
    Sept 202427
    Dec 202425
    Mar 202527
    Jun 202521
    Sept 202523
    Dec 202525
    Mar 202623
    Jun 202622
  • Profit
  • ₹ crore

    Jun 202667

    Quarter₹ croreYoY
    Jun 202461-3.1%
    Sept 202472+9.1%
    Dec 202477+31.1%
    Mar 202594+94.2%
    Jun 202559-3.1%
    Sept 202564-12.0%
    Dec 202573-5.2%
    Mar 202666-29.6%
    Jun 202667+13.1%
  • Per share
  • ₹ per share

    Jun 20261.66

    Quarter₹ per share
    Jun 20247.58
    Sept 20241.80
    Dec 20241.91
    Mar 20252.34
    Jun 20251.47
    Sept 20251.59
    Dec 20251.81
    Mar 20261.65
    Jun 20261.66
  • Leverage
  • Debt to equity

    times

    Jun 20260.00x

    Quartertimes
    Jun 20240.00x
    Sept 20240.00x
    Dec 20240.00x
    Mar 20250.00x
    Jun 20250.00x
    Sept 20250.00x
    Dec 20250.00x
    Mar 20260.00x
    Jun 20260.00x
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
327363348346373430442456484
Revenue YoY+9.5%+14.9%+15.0%+13.5%+14.1%+18.4%+27.2%+31.9%+29.5%
5721241213141831
333370368370386443456474514
Cost structure
626057586876747285
251271266260306356358378426
Exceptional items and tax
82991021218086988989
212725272123252322
Profit
617277945964736667
Net profit YoY-3.1%+9.1%+31.1%+94.2%-3.1%-12.0%-5.2%-29.6%+13.1%
Per share
7.581.801.912.341.471.591.811.651.66
Leverage
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.